Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul;22(7):789-98.
doi: 10.1007/s00192-011-1384-5. Epub 2011 Mar 22.

Incidence and management of graft erosion, wound granulation, and dyspareunia following vaginal prolapse repair with graft materials: a systematic review

Collaborators, Affiliations

Incidence and management of graft erosion, wound granulation, and dyspareunia following vaginal prolapse repair with graft materials: a systematic review

Husam Abed et al. Int Urogynecol J. 2011 Jul.

Abstract

Introduction and hypothesis: This study describes the incidence, risk factors, and treatments of graft erosion, wound granulation, and dyspareunia as adverse events following vaginal repair of pelvic organ prolapse with non-absorbable synthetic and biologic graft materials.

Methods: A systematic review in Medline of reports published between 1950 and November 2010 on adverse events after vaginal prolapse repairs using graft materials was carried out.

Results: One hundred ten studies reported on erosions with an overall rate, by meta-analysis, of 10.3%, (95% CI, 9.7 - 10.9%; range, 0 - 29.7%; synthetic, 10.3%; biological, 10.1%). Sixteen studies reported on wound granulation for a rate of 7.8%, (95% CI, 6.4 - 9.5%; range, 0 - 19.1%; synthetic, 6.8%; biological, 9.1%). Dyspareunia was described in 70 studies for a rate of 9.1%, (95% CI, 8.2 - 10.0%; range, 0 - 66.7%; synthetic, 8.9%; biological, 9.6%).

Conclusions: Erosions, wound granulation, and dyspareunia may occur after vaginal prolapse repair with graft materials, though rates vary widely across studies.

PubMed Disclaimer

References

    1. Control Clin Trials. 1986 Sep;7(3):177-88 - PubMed
    1. Obstet Gynecol. 1997 Apr;89(4):501-6 - PubMed
    1. Int Urogynecol J Pelvic Floor Dysfunct. 1998;9(4):200-4 - PubMed
    1. Acta Obstet Gynecol Scand. 2008;87(9):972-4 - PubMed
    1. Urology. 2009 Oct;74(4):765-70 - PubMed

Publication types

LinkOut - more resources